J Clin Outcomes Manage
Management of stable COPD: focus on pharmacotherapy
Hatipoglu U, Aboussouan L
Abstract Objective: To review contemporary concepts and agents used in pharmacotherapy for chronic obstructive pulmonary disease (COPD). Methods: Qualitative assessment of recent trials with emphasis on impact of pharmacotherapy on clinical outcome measures. Results: Pharmacotherapy for COPD has become multifaceted to reflect the pathogenesis of the condition. Long-acting anti-muscarinic agents, long-acting ?2-agonists, inhaled corticosteroids in combination with long-acting ?2-agonists, phosphodiesterase inhibitors, and mucolytics have been associated with improved outcomes. Combination therapies incorporating different classes of medications hold promise for altering disease progression. Conclusion: Pharmacotherapy holds promise in significantly altering disease progression in COPD in addition to providing symptom relief.
Clinical Review Article
Search the Turner White index to find abstracts of articles published in JCOM.